Our Bureau

HYDERABAD: Aurobindo Pharma Ltd has announced that the US Food and Drug Administration (FDA) has approved its Cephalexin capsules 250 mg and 500 mg.

In a press release here on Monday, the company said this is the first product approval from its dedicated Cephalosporin facility at unit-VI in Medak district of Andhra Pradesh.

At present, products from unit-III alone are contributing to the company's sales in the US.

The company expects to capitalise on the US FDA approvals for the products from units XII and VI.